Vive Sharma
Executive Chairman
Notable Quotes
Our three-pillar structure, Pharma CDMO, specialty chemicals, and API plus continues to provide a resilient foundation for growth.
Our niche technology revenue share has risen from the high teens in FY25 to above 20% in Q1 FY26 and is on track to approach the mid-20s by the end of FY26.